Journal
JOURNAL OF NEUROSCIENCE METHODS
Volume 116, Issue 1, Pages 29-34Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/S0165-0270(02)00025-0
Keywords
mitogen-activated protein kinase; protein phosphorylation; kinase assays
Categories
Funding
- NIMH NIH HHS [MH 00967, MH 55208] Funding Source: Medline
- NINDS NIH HHS [NS 25134] Funding Source: Medline
Ask authors/readers for more resources
The first physiological substrate identified for the extracellular signal-regulated protein kinases (ERKs) is serine 31 in tyrosine hydroxylase (TH), the rate-limiting enzyme in catecholamine biosynthesis. In the present studies, several synthetic peptides modeled after Ser31 in TH were evaluated as in vitro substrates for the ERKs. The phosphorylation of Ser31-containing peptides from type 1 human TH by activated, recombinant ERK2 was found to exhibit catalytic efficiencies (V-max/K-m) up to 4-fold higher than that of a synthetic myelin basic protein (MBP)-based peptide. Both types of peptides were also tested using extracts from PC12 cells (untreated or treated with nerve growth factor (NGF)). Although, the phosphorylation of the MBP peptide by extracts of PC12 cells was higher than that of the Ser31 peptide, the relative treatment-dependent increase was much greater for the Ser31 peptide and more closely mimicked the pattern of ERK phosphorylation, suggesting that the latter peptide may be a more specific substrate for the ERKs. (C) 2002 Elsevier Science B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available